Better Survival with Three-Dimensional Conformal Radiotherapy Than with Conventional Radiotherapy for Cervical Cancer: A Population-Based Study

Table 2

Crude and adjusted hazard ratio for the two groups in the 5-year follow-up period.

	Event %	Unadjusted HR	P  value	Adjusted HR	P  value
		(95% CI)		(95% CI)
Cervical cancer patients with 3D treatment (𝑛=644)	67 (10.4)	1	0.008	1	0.009
Cervical cancer patients with 2D treatment (𝑛=132)	29 (22.0)	1.80 (1.16–2.79)		1.82 (1.16–2.85)

Adjusted for age, diabetes mellitus, hypertension, coronary heart disease, hyperlipidemia, side effects, urbanization level, geographic region, and enrollee category.